{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:53:43Z","timestamp":1782791623893,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2020YFA0710800"],"award-info":[{"award-number":["2020YFA0710800"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cellimm.2025.105046","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:59:51Z","timestamp":1761868791000},"page":"105046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mesenchymal stromal cells relieved systemic lupus erythematosus via CCL2 dependent macrophage polarization"],"prefix":"10.1016","volume":"418","author":[{"given":"Xin","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2025.105046_bb0005","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0961203320932219","article-title":"Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.cellimm.2025.105046_bb0010","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2025.105046_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246231","article-title":"B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments","volume":"20","author":"Yap","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2025.105046_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2025.105046_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11926-017-0708-y","article-title":"Renal macrophages and dendritic cells in SLE nephritis","volume":"19","author":"Maria","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.cellimm.2025.105046_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s10020-024-00866-z","article-title":"Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis","volume":"30","author":"Zhao","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.cellimm.2025.105046_bb0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1574884713666180403150359","article-title":"Lupus nephritis: a treatment update","volume":"13","author":"Aziz","year":"2018","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.cellimm.2025.105046_bb0040","article-title":"Mesenchymal stem cell therapy: Hope for patients with systemic lupus erythematosus","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2025.105046_bb0045","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41467-019-10491-8","article-title":"Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients","volume":"10","author":"Yuan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2025.105046_bb0050","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ebiom.2019.06.016","article-title":"Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2","volume":"45","author":"Zhang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cellimm.2025.105046_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2018.06.002","article-title":"TGF-beta and mesenchymal stromal cells in regenerative medicine, autoimmunity and cancer","volume":"43","author":"de Araujo","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cellimm.2025.105046_bb0060","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/art.38674","article-title":"A CD8 T cell\/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus","volume":"66","author":"Wang","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellimm.2025.105046_bb0065","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3889\/oamjms.2018.404","article-title":"The role of TNF-alpha induced MSCs on suppressive inflammation by increasing TGF-beta and IL-10","volume":"6","author":"Putra","year":"2018","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"10.1016\/j.cellimm.2025.105046_bb0070","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar4520","article-title":"Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellimm.2025.105046_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107598","article-title":"MCP-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2025.105046_bb0080","article-title":"CCL2 deficient mesenchymal stem cells fail to establish long-lasting contact with T cells and no longer ameliorate lupus symptoms","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellimm.2025.105046_bb0085","article-title":"Dissecting heterogeneity reveals a unique BAMBI(high) MFGE8(high) subpopulation of human UC-MSCs","volume":"10","author":"Chen","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.cellimm.2025.105046_bb0090","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1089\/scd.2011.0447","article-title":"Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"21","author":"Li","year":"2012","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.cellimm.2025.105046_bb0095","first-page":"390","article-title":"The monocyte-macrophage system in the human","volume":"137","author":"Speer","year":"1989","journal-title":"Monatsschr. Kinderheilkd."},{"key":"10.1016\/j.cellimm.2025.105046_bb0100","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1601515","article-title":"Akt Signaling pathway in macrophage activation and M1\/M2 polarization","volume":"198","author":"Vergadi","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2025.105046_bb0105","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","article-title":"Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (the TRIDENT study)","volume":"121","author":"Florea","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.cellimm.2025.105046_bb0110","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/sctm.15-0352","article-title":"Video bioinformatics analysis of human pluripotent stem cell morphology, quality, and cellular dynamics","volume":"10","author":"Lin","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.cellimm.2025.105046_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s13287-021-02430-6","article-title":"Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis","volume":"12","author":"Xie","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.cellimm.2025.105046_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature22312","article-title":"Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations","volume":"545","author":"Merkle","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2025.105046_bb0125","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1089\/ten.tea.2014.0535","article-title":"Differential effects of culture senescence and mechanical stimulation on the proliferation and leiomyogenic differentiation of MSC from different sources: implications for engineering vascular grafts","volume":"21","author":"Koobatian","year":"2015","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.cellimm.2025.105046_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102499","article-title":"Investigating the differential therapeutic efficacy and mechanisms of human umbilical cord mesenchymal stem cells at various passages in osteoarthritis treatment","volume":"90","author":"Zhang","year":"2024","journal-title":"Tissue Cell"},{"key":"10.1016\/j.cellimm.2025.105046_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13287-017-0608-0","article-title":"Influences of age-related changes in mesenchymal stem cells on macrophages during in-vitro culture","volume":"8","author":"Yin","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.cellimm.2025.105046_bb0140","first-page":"8","article-title":"Signaling pathways of type i and type iii interferons and targeted therapies in systemic lupus erythematosus","author":"Chyuan","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cellimm.2025.105046_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052505","article-title":"Type I interferons in systemic lupus erythematosus: a journey from bench to bedside","volume":"23","author":"Sim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2025.105046_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3899\/jrheum.210391","article-title":"High systemic type I interferon activity is associated with active class III\/IV lupus nephritis","volume":"49","author":"Iwamoto","year":"2022","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cellimm.2025.105046_bb0155","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/sctm.17-0002","article-title":"Serum IFN-gamma predicts the therapeutic effect of mesenchymal stem cells transplantation in systemic lupus erythematosus patients","volume":"6","author":"Wang","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.cellimm.2025.105046_bb0160","doi-asserted-by":"crossref","first-page":"18335","DOI":"10.1038\/s41598-021-97435-9","article-title":"Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma","volume":"11","author":"Kulach","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874925001327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874925001327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:53:41Z","timestamp":1768485221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874925001327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"alternative-id":["S0008874925001327"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2025.105046","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cells relieved systemic lupus erythematosus via CCL2 dependent macrophage polarization","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2025.105046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105046"}}